Trending stocks

Fortis Malar Hospitals reports 20.1% EBITDA decline in 2016 while 9.9% Revenue growth

24-05-2016 • About Fortis Malar Hospitals ($FORTISMLR) • By InTwits

Fortis Malar Hospitals reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • EBITDA Margin is declining: 4.7% in FY2016 vs. 6.4% in FY2015 vs. 14.7% in FY2012
  • EBITDA Margin is quite volatile: 4.7% in FY2016, 6.4% in FY2015, 8.3% in FY2014, 12.5% in FY2013, 14.7% in FY2012
Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.

Revenue and profitability


Fortis Malar Hospitals's Revenue increased on 9.9%. Revenue decline was accompanies by EBITDA margin decline. EBITDA Margin dropped on 10.9 pp from 4.5% to -6.4% in FY2016. EBITDA Margin declined at -2.6 pp per annum in FY2012-FY2016.

Net Income margin decreased slightly on 1.7 pp from 6.7% to 5.0% in FY2016. During FY2012-FY2016 Net Income margin topped in FY2013 at 44.9% and was declining since that time.

Financial and operational results


Fortis Malar Hospitals ($FORTISMLR) key annual financial indicators

mln. INR201220132014201520162016/2015
P&L
Revenue9489691,0771,1761,2939.9%
EBITDA139121897560-20.1%
Net Income78435887964-18.5%
Balance Sheet
Cash730
Short Term Debt250
Long Term Debt466
Cash flow
Capex98
Ratios
Revenue growth13.5%2.2%11.1%9.2%9.9%
EBITDA growth12.5%-12.9%-26.2%-15.6%-20.1%

EBITDA Margin14.7%12.5%8.3%6.4%4.7%-1.8%
Net Income Margin8.2%44.9%8.1%6.7%5.0%-1.7%
CAPEX, % of revenue10.4%

ROIC27.7%15.9%
ROE26.1%78.5%
Net Debt/EBITDA0.5x-0.2x0.0x0.0x0.0x

Peers in Healthcare Services


Below we provide Fortis Malar Hospitals benchmarking against other companies in Healthcare Services industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top  FY2012 FY2013 FY2014 FY2015 FY2016
Kovai Medical Center & Hospital ($KOVAI)27.3%33.6%12.4%20.2%-
Dr.Agarwal'S Eye Hospital ($DRAGARWQ)0.7%4.4%4.3%4.2%-
Vimta Labs ($VIMTALABS)-24.9%8.4%-9.3%16.3%
 
Median (3 companies)14.0%24.9%8.4%4.2%16.3%
Fortis Malar Hospitals ($FORTISMLR)-2.2%11.1%9.2%9.9%


Top companies by EBITDA margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kovai Medical Center & Hospital ($KOVAI)20.0%23.9%22.0%23.6%-
N.G.Industries ($NGIND)---17.9%-
Vimta Labs ($VIMTALABS)2.1%19.3%22.6%16.2%-
Kmc Speciality Hospitals (India) ($KMCSHIL)---15.5%-
Dr.Agarwal'S Eye Hospital ($DRAGARWQ)10.7%11.0%8.8%10.9%-
 
Median (7 companies)10.7%19.3%22.0%15.5%-
Fortis Malar Hospitals ($FORTISMLR)14.7%12.5%8.3%6.4%4.7%


Top companies by CAPEX/Revenue, %

Top  FY2012 FY2013 FY2014 FY2015 FY2016
Kovai Medical Center & Hospital ($KOVAI)34.8%3.4%4.5%9.4%-
Vimta Labs ($VIMTALABS)4.4%3.6%7.3%7.1%-
 
Median (2 companies)4.4%3.5%5.9%8.3%-


Top companies by ROIC, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kovai Medical Center & Hospital ($KOVAI)11.5%18.0%18.4%23.0%-
Vimta Labs ($VIMTALABS)-9.9%4.7%13.7%5.0%-
N.G.Industries ($NGIND)14.3%13.1%---
Secunderabad Healthcare ($SECHE)0.2%-0.1%---
Chennai Meenakshi Multispeciality Hospital ($CMMHOSP)11.3%19.8%---
 
Median (8 companies)11.3%15.3%13.7%14.0%-
Fortis Malar Hospitals ($FORTISMLR)27.7%15.9%---


Top companies by Net Debt / EBITDA

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kovai Medical Center & Hospital ($KOVAI)4.5x2.5x2.0x1.1x-
Vimta Labs ($VIMTALABS)10.9x0.5x0.2x0.2x-
N.G.Industries ($NGIND)-0.2x0.8x0.0x0.0x-
Secunderabad Healthcare ($SECHE)48.3x99.8x-0.0x-
Kmc Speciality Hospitals (India) ($KMCSHIL)3.2x2.3x7.7x0.0x-
 
Median (7 companies)4.5x2.3x0.1x0.0x-
Fortis Malar Hospitals ($FORTISMLR)0.5x-0.2x0.0x0.0x0.0x